Xinma Bio
About:
Xinma Bio engages in the development and production of biological products.
Website: http://www.novocodex.cn/
Top Investors: Runtu Touzi, SDIC Capital, Advanced Manufacturing Industry Investment Fund
Description:
Xinma Bio engages in the development and production of biological products. The company has expertise and capacities in genetic engineering development, cell culture, toxin synthesis, ADC coupling, preparation filling, preclinical research, and clinical research. Xinma Bio aims to continuously improve the level of research and development technology.
Total Funding Amount:
400M CNY
Headquarters Location:
Shaoxing, Zhejiang, China
Founded Date:
2016-01-01
Contact Email:
novocodex(AT)zmc.top
Founders:
Number of Employees:
101-250
Last Funding Date:
2022-07-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai